Cargando…
Computational repurposing and preclinical validation of colquhounia root tablets for membranous nephropathy
Autores principales: | Mao, Xia, Wang, Kexin, Liu, Yudong, Su, Xiaohui, Wu, Anguo, Chen, Lin, Wang, Jiangrui, Cai, Beilei, Zhang, Yanqiong, Huang, Feng, Lin, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975455/ https://www.ncbi.nlm.nih.gov/pubmed/36855775 http://dx.doi.org/10.1002/ctm2.1143 |
Ejemplares similares
-
Repurposing a clinically approved prescription Colquhounia root tablet to treat diabetic kidney disease via suppressing PI3K/AKT/NF-kB activation
por: Ma, Zhaochen, et al.
Publicado: (2022) -
Colquhounia Root Tablet Promotes Autophagy and Inhibits Apoptosis in Diabetic Nephropathy by Suppressing CD36 Expression In Vivo and In Vitro
por: Li, Han, et al.
Publicado: (2023) -
Topical Treatment of Colquhounia Root Relieves Skin Inflammation and Itch in Imiquimod-Induced Psoriasiform Dermatitis in Mice
por: Li, Fei, et al.
Publicado: (2022) -
Colquhounia Root Tablet Protects Rat Pulmonary Microvascular Endothelial Cells against TNF-α-Induced Injury by Upregulating the Expression of Tight Junction Proteins Claudin-5 and ZO-1
por: Zhou, Wenjie, et al.
Publicado: (2018) -
Extensive preclinical evaluation of combined mangiferin and glycyrrhizic acid for restricting synovial neovascularization in rheumatoid arthritis
por: Mao, Xia, et al.
Publicado: (2023)